Robert Pinnick is a Nephrology physician affiliated with Oregon Health & Science University. OpenAlex indexes 5 publications with 247 citations (h-index 3).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1501 NE Medical Center Dr
Bend, OR 977016051
Telephone
541-382-2811Provider last certified this registry record 8 Apr 2021.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Calliditas Therapeutics US Inc.Program year20231 payment
- Daiichi Sankyo Inc.Program year20221 payment
- Vifor Pharma, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
38.4%Statin8.9%Atorvastatin Calcium54%Rosuvastatin Calcium21%Simvastatin19%Lovastatin6%Part D<11 patientsBeta blocker6.5%Labetalol Hcl41%Metoprolol Succinate25%Metoprolol Tartrate19%Carvedilol16%Part D≥26 patients+ 13 more classes in this area
Nervous system
18.7%Gabapentinoids3.2%Gabapentin80%Pregabalin21%Part D<11 patientsSSRI3%Trazodone Hcl56%Citalopram Hbr33%Sertraline Hcl11%Part D<11 patients+ 12 more classes in this area
Metabolism & gastrointestinal
15.3%Proton pump inhibitor2.9%Pantoprazole Sodium54%Omeprazole46%Part D≥15 patientsPotassium supplement2%Potassium Chloride100%Part D≥20 patients+ 11 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Life-threatening Diphenhydramine Overdose Treated With Charcoal Hemoperfusion and Hemodialysis
Annals of Emergency Medicine
1999 - Filtration by superficial and deep glomeruli of normovolemic and volume-depleted rats
American Journal of Physiology-Renal Physiology
1986 - Regional Citrate Anticoagulation for Hemodialysis in the Patient at High Risk for Bleeding
New England Journal of Medicine
1983 - Refractory hypercalcemia. Management with intravenous fluids and furosemide guided by Swan-Ganz monitoring.
PubMed
1983
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Orwoll, MD
Oregon Health & Science University
Aaron Caughey, MD
Oregon Health & Science University
Tomasz Beer, MD
Oregon Health & Science University
John Nutt, MD
Oregon Health & Science University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”